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The phenomenon of cell size homeostasis, whereby cells coordinate growth and division to maintain
a uniform cell size, has been an outstanding issue in cell biology for many decades. Two recent studies in
Nature in fission yeast demonstrate that a gradient of the polarity factor Pom1 is a sensor of cell length
that determines the onset of Cdc2 activation and mitosis.Morethan100yearsago,Boveri andothers
observed that cells maintain a remarkably
constant size (Wilson, 1925). In order for
cells to achieve size homeostasis, the pro-
cesses of growth and division must be
coordinated (Jorgensen and Tyers, 2004).
In metazoans, cells in each tissue have a
characteristic size that is attuned to tissue
structure and function; cell size can in turn
influence organ and organism size. Micro-
organisms are particularly assiduous in
the management of their size, which is
dynamically controlled by nutrient condi-
tions to optimize competitive fitness. In
both yeast and animal cells, a critical cell
size threshold appears to gate entry into
the division cycle. The size threshold is
plastic and responds to extracellular cues,
such as growth factors or nutrient signals.
Because of the necessary balance
between growth and division, cell size
phenotypes have provided important foot-
holds into understanding how division is
controlled. Most famously, the wee1-50
andcdc2-3wmutations in the fission yeast
Schizosaccharomyces pombe led to the
discovery of the Cdc2 kinase (Cdk1) as
a master regulator of cell division in all
eukaryotes (Nurse, 1990). Analogous ge-
netic approaches in the budding yeast
Saccharomyces cerevisiae helped reveal
the role of cyclins as rate-limiting activa-
torsofCdc2 (Nashetal., 1988). Thesefind-
ings, combined with the identification of
cyclin in marine invertebrates and of other
cdc mutants, were elaborated into the
powerful cyclin-dependent kinase (CDK)
framework that explains fundamental
aspects of cell cycle control from yeast to
humans. However, the means by which
size information, or more properly the rate
of macromolecular synthesis, is sensed
and conveyed to the cell cycle machinery
remains enigmatic.As the name befits, fission yeast divide
by binary fission to produce two equal-
sized daughter cells. During vegetative
growth, the nucleus is positioned at ro-
ughly the cell center, and cell polarity
factors promote longitudinal growth at
the cell tips. In fission yeast, the main
size-control mechanisms operate at the
G2/M transition (Figure 1). Prior tomitosis,
Cdc2 activity is held in a low state by the
Wee1 kinase, which phosphorylates and
inactivatesCdc2; this inhibitoryphosphor-
ylation is reversed by theCdc25 phospha-
tase at the G2/M transition. Wee1 itself
is repressed by the nutrient-responsive
upstream kinases, Cdr2 and Nim1/Cdr1.
In the absence of Wee1, Cdc2 activity is
unrestrained and cells initiate mitosis at
a precociously small size. However, the
mechanism that establishes the size
threshold for Cdc2 activation has until
now eluded discovery.
As reported in a recent issue of Nature
by the groups of Berthelot-Grosjean and
Nurse, a clue to the cell size puzzle lies
in the spatial organization of key deci-
sion-making proteins. Martin and Berthe-
lot-Grosjean began with the key observa-
tion that genetic disruption of a previously
described polarity factor called pom1,
which encodes a kinase of the DYRK
family, causes a small cell size phenotype
(Martin and Berthelot-Grosjean, 2009).
In a complementary approach, Moseley
et al. (2009) first observed that Cdr2 unex-
pectedly localizes to interphase cortical
nodes, dynamic membrane-associated
structures found at the cell midzone. In
late mitosis, the nodes recruit cytokinesis
factors and facilitate formation of the
contractile actomyosin ring; however, a
role for the nodes in mitotic onset had
not been anticipated. The authors demon-
strated that the interphase nodes containDevelopmentalCdr1, Cdr2, another Wee1 inhibitor called
Blt1, Wee1 itself, and other proteins, and
then identified Pom1 as the key polarity
factor required for node localization to
the medial cortex (Moseley et al., 2009).
Genetic and biochemical analysis by both
groups established that Pom1 precludes
premature entry into mitosis by inhibiting
the Cdr2 kinase, which would otherwise
disable the Wee1-dependent inhibition
of Cdc2 (Figure 1). This cascade of nega-
tive regulation is typical of many develop-
mental pathways.
It was immediately obvious that the
inhibitory effect of Pom1 must somehow
be dissipated in order for Cdc2 to be acti-
vated and mitosis to proceed. Critically,
Pom1 and Cdr2 have distinct subcellular
localization patterns: whereas the cortical
nodes that contain Cdr2 are present only
at themedial cortex, live cell imaging anal-
ysis revealed that Pom1 is distributed in
a gradient that runs down from a peak at
thecell tips toa troughat themidcell region
(Figure 1). This Pom1 gradient overlaps
with the interphase nodes in small cells
but the overlap is gradually lost as cells
grow in size. Both groups arrived at the
model that in small cells Cdr2 is phosphor-
ylated and inactivated by Pom1but that as
growth dilutes the Pom1 concentration
below a critical threshold in the midzone,
Cdr2 escapes inhibition by Pom1. As pre-
dicted by this model, even mild extra
dosage of Pom1 delays entry into mitosis
and, most impressively, altering the locali-
zation of Pom1 from the cell tip to the
midzone inhibits division. The dynamic
changes in spatial overlap of Pom1 and
Cdr2 as cells grow in G2 phase thus
constitutes a principal element of the size
threshold in fission yeast.
Many interesting questions are raised
by this model. As genetic dosage studiesCell 17, July 21, 2009 ª2009 Elsevier Inc. 3
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A gradient of Pom1 inhibits Cdr2 at the midzone until cell elongation causes local Pom1 concentration to
fall below a threshold, at which point Cdr2 inhibits Wee1 and liberates Cdc2 to initiate mitosis. Green dots
indicate cortical nodes where Cdr2, Wee1, and other factors are localized. The pathway schematic illus-
trates established functional relationships. The graph illustrates the approximate correlation between
Pom1 concentration at the midzone, Cdr2 activity, and Cdc2 activity.indicate, the Pom1-Cdr2 interaction must
be exquisitely tuned: if too weak, the fre-
quency of Cdr2 phosphorylation would
be too low; if too strong, the two kinases
would colocalize regardless of the
gradient, and Cdr2 would become irre-
versibly inactivated. Similarly, the weak
protein interactions that tether Pom1 to
the cell tip and allow the gradient to form
will be critical, as must be the complex
physical interdependencies that establish
the cortical node structures. Under-
standing the features that tune protein in-
teraction affinities, localization and abun-
dance will enable a quantitative model of
the threshold to be constructed. From the
quantitative perspective, a central issue
is how almost imperceptible changes in
concentration along the gradient are4 Developmental Cell 17, July 21, 2009 ª200converted into the all-or-none decision to
divide. The Wee1-Cdc2 negative and
Cdc25-Cdc2 positive feedback loops
(see Figure 1) are well poised to convert
feeble changes in upstream kinase activi-
ties into a highly cooperative switch-like
decision (Ferrell, 2008). Additional feed-
back circuits between the other kinases
in the pathway may also determine the
timing of this decision. In terms of mecha-
nism, the means by which the kinases in
the interphase nodes communicate with
Cdc2 in the nucleus also needs to be ad-
dressed. The integration of nutrient signals
with the gradient-based size threshold is
also an intriguing question (Petersen and
Nurse, 2007). Finally, as the authors point
out, because pom1 mutants are sub-
stantially larger than wee1 mutants, there9 Elsevier Inc.must be additional players in the size
control network.
The fission yeast gradient model will
come as no surprise to bacterial geneti-
cists and cell biologists who study the
mechanisms of division in diverse bacte-
rial species. In most bacteria, a ring of
the ancestral tubulin FtsZ dictates the
cleavage site. The position of FtsZ ring is
establishedbyagradient of negative regu-
lators that are anchored to cell poles by
a variety of species-specificmechanisms.
For example, in Caulobacter crescentus,
an inhibitor of FtsZ assembly called MipZ
is localized to the cell poles by virtue of
its association with the chromosomal
origin of replication; only cells that have
replicated and separated the origin can
establish the bipolar gradient that drives
FtsZ assembly to themidcell region (Than-
bichler and Shapiro, 2006). In Escherichia
coli, rapidly oscillating gradients of the
division inhibitor MinC also restrict FtsZ
assembly to the midcell (Lutkenhaus,
2007). Evolution has evidently solved the
problem of binary fission by similar
gradient governance mechanisms but
with entirely different component proteins.
How such gradients of biochemical activ-
ities are converted into all-or-none biolog-
ical decisions will no doubt be the focus of
future investigation.
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